Kist de Ruijter, Laura http://orcid.org/0000-0002-2639-3784
van de Donk, Pim P.
Hooiveld-Noeken, Jahlisa S. http://orcid.org/0000-0002-9360-5185
Giesen, Danique
Elias, Sjoerd G. http://orcid.org/0000-0003-3903-4024
Lub-de Hooge, Marjolijn N.
Oosting, Sjoukje F.
Jalving, Mathilde
Timens, Wim http://orcid.org/0000-0002-4146-6363
Brouwers, Adrienne H. http://orcid.org/0000-0003-2698-1516
Kwee, Thomas C.
Gietema, Jourik A.
Fehrmann, Rudolf S. N. http://orcid.org/0000-0002-7516-315X
Fine, Bernard M.
Sanabria Bohórquez, Sandra M.
Yadav, Mahesh
Koeppen, Hartmut
Jing, Jing
Guelman, Sebastian
Lin, Mark T.
Mamounas, Michael J.
Eastham, Jeffrey Ryan
Kimes, Patrick K.
Williams, Simon P.
Ungewickell, Alexander
de Groot, Derk J. A.
de Vries, Elisabeth G. E. http://orcid.org/0000-0002-8949-7425
Funding for this research was provided by:
KWF Kankerbestrijding (10034)
Genentech
Dutch Ministry of Economic Affairs and Climate Policy
Article History
Received: 31 March 2022
Accepted: 12 October 2022
First Online: 5 December 2022
Competing interests
: E.G.E.V. reports funding paid to the institution for clinical trials or contracted research from Amgen, AstraZeneca, Bayer, CytomX, Crescendo Biologics, G1 Therapeutics, GE Healthcare, Genentech, Regeneron, Roche, Servier, Synthon; fees paid to the institution for membership of the advisory board from Daiichi Sankyo, NSABP and Crescendo Biologics. S.F.O. reports research grants from Novartis, Celldex Therapeutics paid to the institution. W.T. reports fees paid to the institution for membership advisory boards from Merck Sharp Dohme and Bristol-Myers-Squibb. M.J. reports fees paid to the institution for membership of the advisory board from BMS, Merck, Novartis, Sanofi, AstraZeneca. J.A.G. reports research grants from Roche, AbbVie, Siemens, paid to the institution. S.M.S.B., M.Y., H.K., J.J., S.G., M.T.L., M.J.M., J.R.E., P.K.K., S.P.W. and A.U. are employees of Genentech Inc., member of the Roche group; M.Y., S.G., M.J.M., S.P.W. and A.U. are also stockholders of Genentech, Inc/Roche. B.M.F. was employee of Genentech, Inc. and stockholder of Roche at time of work described; currently employee and stockholder of Gilead Sciences, Inc. The other authors declare no competing interests.